Pharmacokinetics of BAF312 in Patients With Hepatic Impairment
Clinical trial NCT01565902 · COMPLETED
Trial details
- NCT number
- NCT01565902
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.